Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jan 19, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marinus Pharmaceuticals, Inc.
| 4.6K |
—
|
—
| +26.32% | 22.07K |
Jan 18
| |||||||
Landos Biopharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 23
| |||||||
Marinus Pharmaceuticals, Inc.
| 3.6K |
—
|
—
| +25.95% | 17.48K |
Jan 26
| |||||||
Landos Biopharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Marinus Pharmaceuticals Inc
| 2.75K |
—
|
—
| +24.72% | 13.88K |
Feb 4
| |||||||
Landos Biopharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 17
| |||||||
Landos Biopharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 13
| |||||||
Landos Biopharma, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Esperion Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 28
| |||||||
Marinus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 15
| |||||||
Esperion Therapeutics, Inc.
| 10.7K |
$2.10 | $22,427.20 | +9.55% | 122.7K |
Dec 30
| |||||||
Esperion Therapeutics, Inc.
| 2.5K |
$43.00 | $107,500.00 | +2.28% | 112K |
Mar 11
| |||||||
Esperion Therapeutics, Inc.
| 5K |
$49.00 | $245,000.00 | +4.78% | 109.5K |
Feb 28
| |||||||
Marinus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 8
| |||||||
Esperion Therapeutics, Inc.
| 20.84K |
—
|
—
| +12.64% | 185.67K |
Nov 11 - Jan 2
| |||||||
Esperion Therapeutics, Inc.
| 5K |
$36.98 | $184,900.00 | +6.36% | 83.66K |
Nov 6
| |||||||
Esperion Therapeutics, Inc.
| 7.5K |
$34.55 | $259,106.60 | +10.54% | 78.66K |
Sep 4 - Sep 6
| |||||||
Esperion Therapeutics, Inc.
| 5K |
$39.56 | $197,800.00 | +7.56% | 71.16K |
Aug 1
| |||||||
Esperion Therapeutics, Inc.
| 5K |
$46.00 | $230,000.00 | +8.17% | 66.16K |
Jun 28
| |||||||
Esperion Therapeutics, Inc.
| 5K |
$40.00 | $200,000.00 | +8.90% | 61.16K |
Mar 29
| |||||||
Esperion Therapeutics, Inc.
| 5K |
$43.48 | $217,400.00 | +9.77% | 56.16K |
Mar 20
| |||||||
Esperion Therapeutics, Inc.
| 5K |
$48.73 | $243,650.00 | +10.83% | 51.16K |
Mar 14
| |||||||
Marinus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 26
| |||||||
Loxo Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 15
| |||||||
Esperion Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 28
| |||||||
Loxo Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Loxo Oncology, Inc.
|
0
|
$100.65 | -$1,577,919.32 |
—
|
0
|
Jun 8
| |||||||
Esperion Therapeutics, Inc.
| 4.55K |
$1.17 | $5,324.55 | +10.93% | 46.16K |
Jan 31
| |||||||
Marinus Pharmaceuticals Inc
| 3.3K |
—
|
—
| +7.76% | 45.85K |
Aug 3
| |||||||
Marinus Pharmaceuticals Inc
| 4.5K |
—
|
—
| +9.81% | 50.35K |
Jan 17
| |||||||
Esperion Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 2
| |||||||
Loxo Oncology, Inc.
| -10.00K |
$80.49 | -$804,948.00 | -100.00% |
0
|
Dec 20
|
Scheduled
| ||||||
Marinus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Dec 6
| |||||||
Loxo Oncology, Inc.
|
0
|
$48.38 | -$164,832.60 |
—
| 10K |
Nov 22
| |||||||
Loxo Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Esperion Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 21
| |||||||
Marinus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 17
| |||||||
Esperion Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 3
| |||||||
Marinus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Aug 3
| |||||||
Loxo Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.